Evidence for Change Podcast: Behavioral Science. Commercial Answers.

Atlantis Health
  • 0.0 (0)
  • Business
  • Updated Bimonthly

Evidence for Change Podcast is for pharma Patient Engagement professionals and commercial teams who are tackling real-world challenges in designing, delivering and optimizing initiatives to improve the patient journey. Each episode explores common barriers—from treatment initiation and adherence to digital innovation and scaling globally—through the lens of patient insight and behavioral science expertise. We feature conversations with industry experts in patient engagement, sharing examples and experience to help improve patient engagement outcomes, which in turn supports brand objectives.

Episodes

  1. Aug 5

    Episode 3: From Launch to Legacy: Lessons from a Patient Engagement Program that Delivered for 10+ Years

    Can patient engagement programs improve outcomes and stand the test of time? In episode 3 of Evidence for Change, our guest Peter Said, senior Patient Engagement Strategist and author, joins Jonny Duder, CEO of Atlantis Health and host Charles Beasley to explore the lessons behind the long-running SmartSight patient support program. Together theydiscuss how behavioral science, patient co-design, measurement, and continuous evolution can help transform patient engagement from a short-term initiative into a sustainable driver of better patient outcomes and value. 03:34 Do Patient Engagement Programs Actually Work?10:04 The SmartSight Blueprint from Good Intentions to Real Behavior Change17:45 The Importance of Measuring and Publishing Results27:09 How to Build a Patient Program That Lasts a DecadeSee full episode page: https://resources.atlantishealth.com/from-launch-to-legacy-lessons-from-a-patient-engagement-program-that-delivered-for-10-years

  2. Jun 18

    Episode 2: Global Patient Engagement Solutions: Getting It Right from Strategy to Reality

    In Episode 2 of Evidence for Change, Matt Kowal, Head of Strategy and Commercial Operations at Chiesi USA, and Jonny Duder, CEO of Atlantis Health, explore what it takes to turn global patient engagement strategy into effective local delivery. Drawing on extensive experience across biotech and pharma, they discuss how successful, long-term global programs are built on strong internal sponsorship, organizational commitment, and behavioral science-informed design, then adapted locally to support implementation at scale. The conversation also covers the value of measuring and publishing outcomes, and the role of AI-enabled personalization in global patient engagement. 0:00 Introductions02:31 Chapter 1: Why Most Global Programs Fail Before They Start05:06 Chapter 2: Don't Start With A Solution, Start with Behavior08:57 Chapter 3: The 60/40 Rule: What Should Be Global vs Local10:23 Chapter 4: The Three Non Negotiables of Global Success14:55 Chapter 5: Why Measurement Is The Most Underrated Capability18:00: Chapter 6: Winning the Internal Funding Battle23:05 Chapter 7: Global At Scale, Personal At Heart26:03 Chapter 8: Why Publishing The Evidence Changes Everything33:51 Chapter 9:The One Thing Leaders Must Get RightFull episode page available here: https://resources.atlantishealth.com/evidence-for-change-podcast-global-patient-engagement-strategy-to-reality

  3. May 5

    Episode 1: The Adherence Evidence We Know — and the System & Pharma Change We Need

    Despite decades of evidence, nonadherence to medicines remains a challenge in healthcare. In this first episode of the Evidence for Change Podcast, we explore what 20+ years of adherence evidence has taught us . We discuss why traditional approaches often fall short but also where behavioral science makes a difference in the design of effective patient engagement and adherence support with real world examples. 0:00 Introduction: Welcome to the Evidence–Execution Gap. Why great science doesn’t automatically change care. 3:28 Chapter 1 The Drug Works. The System Doesn’t (Yet). The overlooked patient experience gap. 11:45 Chapter 2: Everyone Else’s Patients. Why clinicians underestimate nonadherence in their own care. 18:04 Chapter 3: Rethinking Pharma’s Role. From medicine supplier to treatment experience partner. 21:11 Chapter 4: Designing for Real Behaviour. Solutions that work because they’re built for humans. 28:24 Chapter 5: Scaling What We Already Know. Why proven solutions still struggle to spread. 30:53 Chapter 6: The Magic Wand Question. What would actually change the system — fast. See full episode page: https://resources.atlantishealth.com/...

  • 3 Episodes

About

Evidence for Change Podcast is for pharma Patient Engagement professionals and commercial teams who are tackling real-world challenges in designing, delivering and optimizing initiatives to improve the patient journey. Each episode explores common barriers—from treatment initiation and adherence to digital innovation and scaling globally—through the lens of patient insight and behavioral science expertise. We feature conversations with industry experts in patient engagement, sharing examples and experience to help improve patient engagement outcomes, which in turn supports brand objectives.

Information